Patent · US Active

Pyrido(3,2-D)pyrimidines and pharmaceutical compositions useful for treating hepatitis C

US8232278B2 · kind B2 · utility

14Cited by
30References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 26, 2006
Grant dateJul 31, 2012
Priority date—
Expiry dateMay 18, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Specifically substituted pyrido(3,2-d)pyrimidine derivatives having the structural formula (I) are useful for the treatment of hepatitis C.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.